Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04296487 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Introduction of ACI for Cartilage Repair

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 100 to 218
    • Primary and study completion dates: Sep 1, 2025 to Sep 2030
    v5
  2. Study sites: 2 to 1v4
  3. Re-verified, no change to tracked fieldsv3
  4. Primary endpoints revised (3)v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study was aimed to evaluate effectiveness and safety of autologous chondrocyte suspension for treatment of knee articular cartilage defects.
Trial Details
NCT Number NCT04296487
Lead Sponsor Centre Hospitalier Universitaire Vaudois
Conditions
(from sponsor)		 Articular Cartilage Defect, Chondral Defect, Osteochondritis
Related terms Osteochondritis
Enrollment 218 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov